Engineering & Construction
Build Your Comparison
Side-by-side financial analysisStock Comparison
BWMN vs HURN vs CASS vs ICFI vs EXPO
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
Specialty Business Services
Consulting Services
Consulting Services
BWMN vs HURN vs CASS vs ICFI vs EXPO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Engineering & Construction | Consulting Services | Specialty Business Services | Consulting Services | Consulting Services |
| Market Cap | $532M | $1.77B | $638M | $1.32B | $2.81B |
| Revenue (TTM) | $377M | $1.74B | $204M | $1.82B | $582M |
| Net Income (TTM) | $11M | $104M | $35M | $85M | $106M |
| Gross Margin | 46.6% | 23.3% | 88.6% | 35.7% | 40.1% |
| Operating Margin | 4.8% | 11.3% | 19.0% | 8.0% | 20.6% |
| Forward P/E | 17.9x | 12.4x | 16.5x | 10.4x | 27.8x |
| Total Debt | $147M | $548M | $5M | $571M | $83M |
| Cash & Equiv. | $11M | $25M | $392M | $5M | $222M |
BWMN vs HURN vs CASS vs ICFI vs EXPO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 21 | Jun 26 | Return |
|---|---|---|---|
| Bowman Consulting G… (BWMN) | 100 | 224.5 | +124.5% |
| Huron Consulting Gr… (HURN) | 100 | 200.0 | +100.0% |
| Cass Information Sy… (CASS) | 100 | 108.4 | +8.4% |
| ICF International, … (ICFI) | 100 | 82.8 | -17.2% |
| Exponent, Inc. (EXPO) | 100 | 62.6 | -37.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BWMN vs HURN vs CASS vs ICFI vs EXPO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BWMN has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 14.9%, EPS growth 329.4%, 3Y rev CAGR 23.3%
- 121.9% 10Y total return vs EXPO's 136.3%
- PEG 0.35 vs EXPO's 4.66
- 14.9% revenue growth vs CASS's -13.1%
Among these 5 stocks, HURN doesn't own a clear edge in any measured category.
CASS is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 24 yrs, beta 0.65, yield 2.5%
- 2.5% yield, 24-year raise streak, vs EXPO's 2.1%, (2 stocks pay no dividend)
- +18.6% vs EXPO's -22.9%
ICFI is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.42, Low D/E 55.6%, current ratio 1.27x
- Beta 0.42, yield 0.8%, current ratio 1.27x
- Beta 0.42 vs BWMN's 1.81, lower leverage
EXPO ranks third and is worth considering specifically for quality and efficiency.
- 18.2% margin vs BWMN's 2.8%
- 13.7% ROA vs CASS's 1.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 14.9% revenue growth vs CASS's -13.1% | |
| Value | Lower P/E (17.9x vs 27.8x), PEG 0.35 vs 4.66 | |
| Quality / Margins | 18.2% margin vs BWMN's 2.8% | |
| Stability / Safety | Beta 0.42 vs BWMN's 1.81, lower leverage | |
| Dividends | 2.5% yield, 24-year raise streak, vs EXPO's 2.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +18.6% vs EXPO's -22.9% | |
| Efficiency (ROA) | 13.7% ROA vs CASS's 1.4% |
BWMN vs HURN vs CASS vs ICFI vs EXPO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BWMN vs HURN vs CASS vs ICFI vs EXPO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CASS leads in 2 of 6 categories
EXPO leads 1 • ICFI leads 1 • BWMN leads 0 • HURN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EXPO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICFI is the larger business by revenue, generating $1.8B annually — 9.0x CASS's $204M. EXPO is the more profitable business, keeping 18.2% of every revenue dollar as net income compared to BWMN's 2.8%. On growth, HURN holds the edge at +14.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $377M | $1.7B | $204M | $1.8B | $582M |
| EBITDAEarnings before interest/tax | $47M | $231M | $44M | $203M | $125M |
| Net IncomeAfter-tax profit | $11M | $104M | $35M | $85M | $106M |
| Free Cash FlowCash after capex | $32M | $124M | $32M | $151M | $122M |
| Gross MarginGross profit ÷ Revenue | +46.6% | +23.3% | +88.6% | +35.7% | +40.1% |
| Operating MarginEBIT ÷ Revenue | +4.8% | +11.3% | +19.0% | +8.0% | +20.6% |
| Net MarginNet income ÷ Revenue | +2.8% | +6.0% | +17.3% | +4.7% | +18.2% |
| FCF MarginFCF ÷ Revenue | +8.5% | +7.1% | +15.6% | +8.3% | +21.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +14.2% | -10.1% | -10.3% | +7.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | +0.8% | +87.9% | -22.2% | +6.5% |
Valuation Metrics
ICFI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, ICFI trades at a 65% valuation discount to BWMN's 42.6x P/E. Adjusting for growth (PEG ratio), BWMN offers better value at 0.84x vs EXPO's 4.63x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $532M | $1.8B | $638M | $1.3B | $2.8B |
| Enterprise ValueMkt cap + debt − cash | $668M | $2.3B | $251M | $1.9B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | 42.56x | 18.74x | 18.95x | 14.70x | 27.57x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.88x | 12.39x | 16.48x | 10.36x | 27.77x |
| PEG RatioP/E ÷ EPS growth rate | 0.84x | — | 2.21x | 1.28x | 4.63x |
| EV / EBITDAEnterprise value multiple | 14.37x | 9.92x | 6.46x | 8.98x | 20.58x |
| Price / SalesMarket cap ÷ Revenue | 1.09x | 1.04x | 3.34x | 0.70x | 4.83x |
| Price / BookPrice ÷ Book value/share | 1.99x | 3.72x | 2.74x | 1.30x | 7.49x |
| Price / FCFMarket cap ÷ FCF | 15.91x | 9.70x | 20.09x | 10.96x | 22.98x |
Profitability & Efficiency
Evenly matched — CASS and EXPO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
EXPO delivers a 25.5% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $4 for BWMN. CASS carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HURN's 1.04x. On the Piotroski fundamental quality scale (0–9), CASS scores 8/9 vs HURN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.1% | +21.8% | +14.6% | +8.3% | +25.5% |
| ROA (TTM)Return on assets | +1.9% | +6.8% | +1.4% | +4.1% | +13.7% |
| ROICReturn on invested capital | +3.6% | +15.0% | — | +7.2% | +36.3% |
| ROCEReturn on capital employed | +5.1% | +18.6% | +4.4% | +9.3% | +19.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 8 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.56x | 1.04x | 0.02x | 0.56x | 0.21x |
| Net DebtTotal debt minus cash | $136M | $524M | -$388M | $566M | -$139M |
| Cash & Equiv.Liquid assets | $11M | $25M | $392M | $5M | $222M |
| Total DebtShort + long-term debt | $147M | $548M | $5M | $571M | $83M |
| Interest CoverageEBIT ÷ Interest expense | 3.38x | 7.70x | — | 6.35x | — |
Total Returns (Dividends Reinvested)
CASS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BWMN five years ago would be worth $22,846 today (with dividends reinvested), compared to $6,967 for EXPO. Over the past 12 months, CASS leads with a +18.6% total return vs EXPO's -22.9%. The 3-year compound annual growth rate (CAGR) favors CASS at 9.5% vs ICFI's -15.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.3% | -36.0% | +23.4% | -14.4% | -17.7% |
| 1-Year ReturnPast 12 months | +12.4% | -19.9% | +18.6% | -16.8% | -22.9% |
| 3-Year ReturnCumulative with dividends | +4.2% | +30.6% | +31.4% | -40.3% | -38.0% |
| 5-Year ReturnCumulative with dividends | +128.5% | +112.8% | +20.7% | -19.1% | -30.3% |
| 10-Year ReturnCumulative with dividends | +121.9% | +86.9% | +56.1% | +88.3% | +136.3% |
| CAGR (3Y)Annualised 3-year return | +1.4% | +9.3% | +9.5% | -15.8% | -14.7% |
Risk & Volatility
Evenly matched — CASS and ICFI each lead in 1 of 2 comparable metrics.
Risk & Volatility
ICFI is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than BWMN's 1.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CASS currently trades 94.3% from its 52-week high vs HURN's 58.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.81x | 0.43x | 0.65x | 0.42x | 0.76x |
| 52-Week HighHighest price in past year | $45.83 | $186.78 | $52.45 | $101.71 | $81.95 |
| 52-Week LowLowest price in past year | $26.00 | $100.10 | $36.07 | $58.83 | $51.91 |
| % of 52W HighCurrent price vs 52-week peak | +67.8% | +58.6% | +94.3% | +71.5% | +69.7% |
| RSI (14)Momentum oscillator 0–100 | 47.2 | 41.2 | 67.2 | 60.6 | 41.1 |
| Avg Volume (50D)Average daily shares traded | 105K | 227K | 80K | 337K | 479K |
Analyst Outlook
CASS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BWMN as "Buy", HURN as "Buy", CASS as "Buy", ICFI as "Buy", EXPO as "Buy". Consensus price targets imply 86.7% upside for BWMN (target: $58) vs 3.1% for CASS (target: $51). For income investors, CASS offers the higher dividend yield at 2.48% vs ICFI's 0.77%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $58.00 | $157.50 | $51.00 | $90.00 | $75.00 |
| # AnalystsCovering analysts | 7 | 9 | 2 | 13 | 8 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.5% | +0.8% | +2.1% |
| Dividend StreakConsecutive years of raises | — | 1 | 24 | 0 | 13 |
| Dividend / ShareAnnual DPS | — | — | $1.23 | $0.56 | $1.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.5% | +9.4% | +4.1% | +4.2% | +3.5% |
CASS leads in 2 of 6 categories (Total Returns, Analyst Outlook). EXPO leads in 1 (Income & Cash Flow). 2 tied.
BWMN vs HURN vs CASS vs ICFI vs EXPO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BWMN or HURN or CASS or ICFI or EXPO a better buy right now?
For growth investors, Bowman Consulting Group Ltd.
(BWMN) is the stronger pick with 14. 9% revenue growth year-over-year, versus -13. 1% for Cass Information Systems, Inc. (CASS). ICF International, Inc. (ICFI) offers the better valuation at 14. 7x trailing P/E (10. 4x forward), making it the more compelling value choice. Analysts rate Bowman Consulting Group Ltd. (BWMN) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BWMN or HURN or CASS or ICFI or EXPO?
On trailing P/E, ICF International, Inc.
(ICFI) is the cheapest at 14. 7x versus Bowman Consulting Group Ltd. at 42. 6x. On forward P/E, ICF International, Inc. is actually cheaper at 10. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bowman Consulting Group Ltd. wins at 0. 35x versus Exponent, Inc. 's 4. 66x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BWMN or HURN or CASS or ICFI or EXPO?
Over the past 5 years, Bowman Consulting Group Ltd.
(BWMN) delivered a total return of +128. 5%, compared to -30. 3% for Exponent, Inc. (EXPO). Over 10 years, the gap is even starker: EXPO returned +136. 3% versus CASS's +56. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BWMN or HURN or CASS or ICFI or EXPO?
By beta (market sensitivity over 5 years), ICF International, Inc.
(ICFI) is the lower-risk stock at 0. 42β versus Bowman Consulting Group Ltd. 's 1. 81β — meaning BWMN is approximately 327% more volatile than ICFI relative to the S&P 500. On balance sheet safety, Cass Information Systems, Inc. (CASS) carries a lower debt/equity ratio of 2% versus 104% for Huron Consulting Group Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — BWMN or HURN or CASS or ICFI or EXPO?
By revenue growth (latest reported year), Bowman Consulting Group Ltd.
(BWMN) is pulling ahead at 14. 9% versus -13. 1% for Cass Information Systems, Inc. (CASS). On earnings-per-share growth, the picture is similar: Bowman Consulting Group Ltd. grew EPS 329. 4% year-over-year, compared to -14. 9% for ICF International, Inc.. Over a 3-year CAGR, BWMN leads at 23. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BWMN or HURN or CASS or ICFI or EXPO?
Cass Information Systems, Inc.
(CASS) is the more profitable company, earning 18. 4% net margin versus 2. 5% for Bowman Consulting Group Ltd. — meaning it keeps 18. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 3. 9% for BWMN. At the gross margin level — before operating expenses — CASS leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BWMN or HURN or CASS or ICFI or EXPO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Bowman Consulting Group Ltd. (BWMN) is the more undervalued stock at a PEG of 0. 35x versus Exponent, Inc. 's 4. 66x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ICF International, Inc. (ICFI) trades at 10. 4x forward P/E versus 27. 8x for Exponent, Inc. — 17. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BWMN: 86. 7% to $58. 00.
08Which pays a better dividend — BWMN or HURN or CASS or ICFI or EXPO?
In this comparison, CASS (2.
5% yield), EXPO (2. 1% yield), ICFI (0. 8% yield) pay a dividend. BWMN, HURN do not pay a meaningful dividend and should not be held primarily for income.
09Is BWMN or HURN or CASS or ICFI or EXPO better for a retirement portfolio?
For long-horizon retirement investors, ICF International, Inc.
(ICFI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), 0. 8% yield). Bowman Consulting Group Ltd. (BWMN) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ICFI: +88. 3%, BWMN: +121. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BWMN and HURN and CASS and ICFI and EXPO?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BWMN is a small-cap quality compounder stock; HURN is a small-cap quality compounder stock; CASS is a small-cap quality compounder stock; ICFI is a small-cap deep-value stock; EXPO is a small-cap quality compounder stock. CASS, ICFI, EXPO pay a dividend while BWMN, HURN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.